Other OTC - Delayed Quote USD

Poniard Pharmaceuticals, Inc. (PARD)

0.0001 0.0000 (0.00%)
As of March 26 at 3:13 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
Operating Expense
15,533.0000
Operating Income
-15,533.0000
Net Non Operating Interest Income Expense
-509.0000
Net Income Common Stockholders
-16,234.0000
Diluted NI Available to Com Stockholders
-16,234.0000
Basic EPS
-12.40
Diluted EPS
-12.40
Basic Average Shares
1,324.2940
Diluted Average Shares
1,324.2940
Total Operating Income as Reported
-15,533.0000
Total Expenses
15,533.0000
Net Income from Continuing & Discontinued Operation
-16,042.0000
Normalized Income
-16,042.0000
Interest Income
27.0000
Interest Expense
536.0000
Net Interest Income
-509.0000
EBIT
-15,533.0000
EBITDA
-14,258.0000
Reconciled Depreciation
1,275.0000
Net Income from Continuing Operation Net Minority Interest
-16,042.0000
Normalized EBITDA
-14,258.0000
Tax Rate for Calcs
0.0004
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NTII Neurobiological Technologies, Inc.
0.0000
0.00%
 
AFFY Affymax, Inc.
0.0007
0.00%
 
LABP Landos Biopharma, Inc.
22.46
+0.47%
 
ALVR AlloVir, Inc.
0.7775
-2.81%
 
LQDA Liquidia Corporation
12.46
+0.69%
 
VNDA Vanda Pharmaceuticals Inc.
4.5700
+2.01%